Resistance to Targeted Anti-Cancer Therapeutics

Yarden, Yosef; Elkabets, Moshe

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.

Details

Published by: Springer

Publication Date: 2019-02-02

Format: Paperback

ISBN-13: 9783030098179

DOI: 10.1007/978-3-319-67932-7

Dimensions: 235cm x155cm

Pages: 242